Breaking: Insulin Biosimilars Market Poised for Significant Expansion by 2035
The Insulin Biosimilars Market is on track for substantial growth, with projections estimating a market size of USD 12.04 billion by 2035. This reflects an impressive compound annual growth rate (CAGR) of 7.27% from its current valuation of USD 5.54 billion in 2024. As the demand for affordable diabetes management continues to rise, particularly in North America and the Asia-Pacific regions,...
0 Comments 0 Shares 81 Views 0 Reviews